Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117167) titled 'A Randomized Controlled Clinical Study of Mulberry Twig Alkaloids Tablets versus Dapagliflozin in Patients with Type 2 Diabetes: Efficacy and Safety Evaluation' on Jan. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: NanJing First Hospital
Condition:
T2DM
Intervention:
Intervention Group:Mulberry Twig Total Alkaloids Tablets
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-02-01
Target Sample Size: Intervention Group:168;Dapagliflozin Group:56;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=298...